Vestcor Inc Teva Pharmaceutical Industries LTD Transaction History

Vestcor Inc

$2.96 Billion
Q2 2024

A detailed history of Vestcor Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Vestcor Inc holds 14,906 shares of TEVA stock, worth $260,855. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,906

Previous 17,076 12.71%

Holding current value

$260,855

Previous $241,000 0.41%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$12.78 - $17.4 $27,732 - $37,758	-2,170 Reduced 12.71%	14,906 $242,000
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $22,896 - $32,752	-3,061 Reduced 15.2%	17,076 $174,000
Q2 2023 Aug 15, 2023	SELL	$7.2 - $9.47 $45,777 - $60,210	-6,358 Reduced 24.0%	20,137 $152,000
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $12,983 - $17,657	1,553 Added 6.23%	26,495 $234,000
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $27,446 - $38,677	-3,719 Reduced 12.98%	24,942 $188,000
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $9,419 - $12,066	-1,285 Reduced 4.29%	28,661 $269,000
Q4 2021 Feb 15, 2022	SELL	$7.9 - $10.19 $21,235 - $27,390	-2,688 Reduced 8.24%	29,946 $240,000
Q1 2021 May 17, 2021	BUY	$10.34 - $12.81 $47,191 - $58,464	4,564 Added 16.26%	32,634 $377,000
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $2,346 - $3,791	-289 Reduced 1.02%	28,070 $346,000
Q1 2020 May 13, 2020	BUY	$6.69 - $13.45 $70,271 - $141,278	10,504 Added 58.83%	28,359 $255,000
Q4 2019 Feb 12, 2020	BUY	$6.53 - $10.72 $116,593 - $191,405	17,855 New	17,855 $175,000

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.

Account